Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated: April 2, 2026, 3:20 am
Author: Getaka|Social: XLinkedIn

Metropolis Healthcare Ltd: Intrinsic Value & Share Price Analysis

Fair Value

₹320.53Overvalued by 24.40%vs CMP ₹424.00

P/E (50.3) × ROE (11.5%) × BV (₹69.10) × DY (0.24%)

₹187.29Overvalued by 55.83%vs CMP ₹424.00
MoS: -126.4% (Negative)Confidence: 68/100 (Moderate)Models: All 9: Overvalued
ModelCategoryValueWeightSignal
PE-ROEEarnings₹304.7122%Over (-28.1%)
Graham NumberEarnings₹224.7516%Over (-47%)
Earnings PowerEarnings₹46.9513%Over (-88.9%)
DCFCash Flow₹70.7613%Over (-83.3%)
Net Asset ValueAssets₹69.037%Over (-83.7%)
EV/EBITDAEnterprise₹231.529%Over (-45.4%)
Earnings YieldEarnings₹324.907%Over (-23.4%)
ROCE CapitalReturns₹206.579%Over (-51.3%)
Revenue MultipleRevenue₹96.245%Over (-77.3%)
Consensus (9 models)₹187.29100%Overvalued
Key Drivers: Wide model spread (₹47–₹325) — high uncertainty.

PE-ROE · Graham · EPV · DCF · NAV · EV/EBITDA · DDM · Earnings Yield · ROCE Capital · Revenue Multiple | CoE: 12% · Terminal: 4% · EPS CAGR: -4.9%

*Investments are subject to market risks

Investment Snapshot

62
Metropolis Healthcare Ltd scores 62/100 (Average)
Based on 5 dimensions: health, institutional flow, earnings quality, momentum, and peer comparison
Stock Health76/100 · Strong
ROCE 14.7% GoodROE 11.5% AverageD/E 0.00 Low debtInterest Coverage 0.0x RiskyProfitable 5/5 years Consistent
Smart Money45/100 · Moderate
FII holding down -3.61% (6mo) SellingDII holding up 4.43% MF buyingPromoter holding at 48.9% Stable
Earnings Quality50/100 · Moderate
OPM contracting (27% → 24%) DecliningWorking capital: -18 days (improving) Efficient
Quarterly Momentum68/100 · Strong
Revenue (4Q): +19% YoY GrowingProfit (4Q): +10% YoY Positive
Industry Rank60/100 · Moderate
P/E 50.3 vs industry 75.2 Cheaper than peersROCE 14.7% vs industry 14.7% Average3Y sales CAGR: 3% Slow

Weights: Health 30% · Earnings Quality 25% · Momentum 20% · Industry Rank 15% · Smart Money 10%. Scores are computed from reported financials and recalculated daily. Not investment advice.

Metropolis Healthcare Ltd Investor Signals

Computed from valuation, cash flow, balance sheet, ownership and quarterly trend data already available in this stock page.

Value Trap Score
50/100
Moderate
Derived from: Cheapness + weak quality + weak cash support
Current data: P/E 50.3 vs Ind 75.2 | ROCE 14.7% | ROE 11.5% | CFO/NP N/A
Balance Sheet Stress
0/100
Comfortable
Derived from: Leverage + debt servicing + liquidity + debt trend
Current data: D/E 0.00x | IntCov 0.0x | Current 2.98x | Borrow/Reserve 0.14x
Cash Flow Reliability
43/100
Mixed
Derived from: Cash backing of earnings + working capital pressure
Current data: CFO ₹0 Cr | NP ₹146 Cr | CFO/NP N/A
Ownership Accumulation
-25
Neutral
Derived from: FII + DII + promoter direction, adjusted by crowding
Current data: FII -0.84 pp | DII +1.63 pp | Prom -0.02 pp
Business Momentum
-38
Early weakness
Derived from: Latest quarter sales + profit + OPM change
Current data: Q Sales -5.4% | Q NP -20.8% | Q OPM -2.0 pp
Derived FieldValueHow it is derived
Valuation Gap %-55.8%((Fair Value - CMP) / CMP) × 100
Borrowings / Reserves0.14xLatest borrowings divided by latest reserves
CFO / Net ProfitN/ALatest operating cash flow divided by latest net profit
FII Change-0.84 ppLatest FII% minus previous FII%
DII Change+1.63 ppLatest DII% minus previous DII%
Promoter Change-0.02 ppLatest promoter% minus previous promoter%
Shareholder Count Change-1,176Latest shareholder count minus previous count
Quarterly Sales Change-5.4%Latest quarter sales vs previous quarter sales
Quarterly Profit Change-20.8%Latest quarter net profit vs previous quarter net profit
Quarterly OPM Change-2.0 ppLatest quarter OPM minus previous quarter OPM

Share Price and Basic Stock Data

Last Updated: April 2, 2026, 3:20 am

Market Cap 8,796 Cr.
Current Price 424
Intrinsic Value₹187.29
High / Low 566/329
Stock P/E50.3
Book Value 69.1
Dividend Yield0.24 %
ROCE14.7 %
ROE11.5 %
Face Value 2.00
PEG Ratio-10.19

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Metropolis Healthcare Ltd

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Metropolis Healthcare Ltd 8,796 Cr. 424 566/32950.3 69.10.24 %14.7 %11.5 % 2.00
Healthcare Global Enterprises Ltd 7,990 Cr. 535 800/498294 61.70.00 %8.56 %5.14 % 10.0
Thyrocare Technologies Ltd 5,762 Cr. 362 538/22043.8 32.41.93 %26.5 %17.4 % 10.0
Indraprastha Medical Corporation Ltd 3,664 Cr. 400 641/32220.0 71.81.13 %39.1 %30.0 % 10.0
Artemis Medicare Services Ltd 3,528 Cr. 223 306/20335.5 56.00.20 %14.9 %12.9 % 1.00
Industry Average26,819.31 Cr611.5975.1783.710.36%14.71%13.91%9.04

All Competitor Stocks of Metropolis Healthcare Ltd

Quarterly Result

MetricDec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales 285283277308291331313350323345386429406
Expenses 215212214234226251235260251283296321311
Operating Profit 707063756580799072629010895
OPM % 25%25%23%24%22%24%25%26%22%18%23%25%23%
Other Income 713123233781-0
Interest 6666565555566
Depreciation 23232122252626272829313232
Profit before tax 48423948375151614236617157
Tax % 25%20%26%26%26%28%25%24%26%19%26%26%26%
Net Profit 36332936273738473129455342
EPS in Rs 6.996.515.626.925.307.117.419.086.125.638.7010.177.99

Last Updated: February 5, 2026, 12:40 am

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: February 25, 2026, 1:16 am

MetricMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales 3884564755456477618569981,2281,1481,2081,3311,566
Expenses 2853393594054675596197088808559201,0231,211
Operating Profit 104117116140181203237290348293288308355
OPM % 27%26%24%26%28%27%28%29%28%26%24%23%23%
Other Income 107293968-1712341591515
Interest 32224413122532282421
Depreciation 1621171719203946638994109124
Profit before tax 95101128160164187169244293188175191225
Tax % 34%33%36%33%32%34%24%25%27%24%26%24%
Net Profit 636882107112124128183215143128146169
EPS in Rs 57.3461.8280.47106.52109.2323.9425.1535.8241.8527.9024.9527.9932.49
Dividend Payout % 2%0%100%49%0%55%32%22%19%29%16%0%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-20242024-2025
YoY Net Profit Growth (%)7.94%20.59%30.49%4.67%10.71%3.23%42.97%17.49%-33.49%-10.49%14.06%
Change in YoY Net Profit Growth (%)0.00%12.65%9.90%-25.81%6.04%-7.49%39.74%-25.48%-50.97%23.00%24.55%

Metropolis Healthcare Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:11%
5 Years:9%
3 Years:3%
TTM:13%
Compounded Profit Growth
10 Years:9%
5 Years:-1%
3 Years:-12%
TTM:11%
Stock Price CAGR
10 Years:%
5 Years:4%
3 Years:17%
1 Year:4%
Return on Equity
10 Years:20%
5 Years:17%
3 Years:13%
Last Year:12%

Last Updated: Unknown

Balance Sheet

Last Updated: December 10, 2025, 3:05 am

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital 10101010101010101010101010
Reserves 2923522693144054085136968769781,0861,3211,422
Borrowings 20145111867112379266197204201
Other Liabilities 6987107188110113160181256240254324359
Total Liabilities 3914623915125265507501,0001,5211,4951,5471,8591,993
Fixed Assets 1491531422022072132963431,0591,1211,1771,4471,573
CWIP 10110630620000
Investments 1321681011421023314101615557121
Other Assets 109141147167216298437647440340316341399
Total Assets 3914623915125265507501,0001,5211,4951,5471,8591,993

Reserves and Borrowings Chart

Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity + 77699110210490215249253247264263
Cash from Investing Activity + -61-5696-86136-10463-73648-89-199
Cash from Financing Activity + -14-9-174-17-87-118-55-33163-292-181-87
Net Cash Flow 2414-118856279-3213-6-23
Free Cash Flow 534679459067179221223195200196
CFO/OP 103%87%113%109%89%78%118%106%96%102%105%99%

Free Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Free Cash Flow84.00103.00111.00139.00180.00185.00170.00178.00-31.0027.0091.00104.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 475754545766554540393841
Inventory Days 475246385355445968645865
Days Payable 759296978890152160136136150171
Cash Conversion Cycle 19173-52130-54-56-29-33-53-65
Working Capital Days 22328-2728332-9-26-22-16-18
ROCE %28%34%46%43%43%40%36%29%17%16%15%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Promoters 49.75%49.75%49.75%49.74%49.67%49.62%49.43%49.40%48.89%48.89%48.89%48.87%
FIIs 25.67%25.66%24.29%21.66%18.90%18.25%18.56%16.73%15.29%12.83%12.52%11.68%
DIIs 13.64%14.89%16.86%20.73%24.86%27.42%28.02%30.00%30.30%32.40%33.10%34.73%
Public 10.94%9.69%9.10%7.87%6.57%4.69%3.98%3.86%5.51%5.87%5.48%4.69%
No. of Shareholders 84,26989,69286,24979,87868,28358,10851,85248,57249,29350,01547,84646,670

Shareholding Pattern Chart

No. of Shareholders

Metropolis Healthcare Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
HDFC Focused Fund 1,700,000 1.21 318.41N/AN/AN/A
HDFC Flexi Cap Fund 1,625,000 0.31 304.36N/AN/AN/A
Kotak Small Cap Fund 1,506,802 1.72 282.221,346,0432026-02-23 06:55:3211.94%
Nippon India Small Cap Fund 1,145,336 0.33 214.521,085,4112025-12-08 00:54:445.52%
HDFC ELSS Tax Saver Fund 800,000 0.89 149.84N/AN/AN/A
Canara Robeco Small Cap Fund 743,790 1.1 139.31719,0042026-01-25 01:35:373.45%
Franklin India Small Cap Fund 715,459 1.05 134.01790,4592025-12-14 00:32:36-9.49%
Aditya Birla Sun Life Flexi Cap Fund 700,000 0.53 131.11506,0152025-12-08 00:54:4438.34%
Franklin India Opportunities Fund 649,673 1.47 121.68N/AN/AN/A
HDFC Hybrid Equity Fund 612,876 0.48 114.79N/AN/AN/A

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 2.002.002.002.002.00
Basic EPS (Rs.) 28.2924.9527.9141.8735.97
Diluted EPS (Rs.) 28.1524.8727.9141.6635.79
Cash EPS (Rs.) 49.0743.5245.4254.3144.86
Book Value[Excl.RevalReserv]/Share (Rs.) 256.94213.98193.46173.56138.52
Book Value[Incl.RevalReserv]/Share (Rs.) 256.94213.98193.46173.56138.52
Revenue From Operations / Share (Rs.) 256.99235.76224.21240.04195.24
PBDIT / Share (Rs.) 61.4156.9459.2770.4358.31
PBIT / Share (Rs.) 40.4338.5041.8558.0849.32
PBT / Share (Rs.) 36.8434.1036.6157.3347.80
Net Profit / Share (Rs.) 28.0925.0828.0041.9535.87
NP After MI And SOA / Share (Rs.) 27.9924.9527.9041.8635.82
PBDIT Margin (%) 23.8924.1526.4329.3429.86
PBIT Margin (%) 15.7316.3318.6624.1925.26
PBT Margin (%) 14.3314.4616.3323.8824.48
Net Profit Margin (%) 10.9310.6312.4817.4718.37
NP After MI And SOA Margin (%) 10.8910.5812.4417.4318.34
Return on Networth / Equity (%) 10.8911.6614.4524.1125.91
Return on Capital Employeed (%) 13.3115.0617.3224.1831.49
Return On Assets (%) 7.768.219.5113.9918.22
Long Term Debt / Equity (X) 0.000.000.020.170.00
Total Debt / Equity (X) 0.010.000.070.290.00
Asset Turnover Ratio (%) 0.770.790.750.950.96
Current Ratio (X) 1.181.281.141.302.98
Quick Ratio (X) 1.011.130.971.132.78
Inventory Turnover Ratio (X) 30.7729.000.000.000.00
Dividend Payout Ratio (NP) (%) 0.0016.0328.6719.1122.33
Dividend Payout Ratio (CP) (%) 0.009.2117.6514.7517.85
Earning Retention Ratio (%) 0.0083.9771.3380.8977.67
Cash Earning Retention Ratio (%) 0.0090.7982.3585.2582.15
Interest Coverage Ratio (X) 17.1312.9411.3218.2638.30
Interest Coverage Ratio (Post Tax) (X) 8.836.706.3511.0724.56
Enterprise Value (Cr.) 8063.198775.736384.2710513.8111037.23
EV / Net Operating Revenue (X) 6.067.275.568.5611.06
EV / EBITDA (X) 25.3530.0921.0329.1737.03
MarketCap / Net Operating Revenue (X) 6.087.325.578.4811.48
Retention Ratios (%) 0.0083.9671.3280.8877.66
Price / BV (X) 6.088.076.4711.7316.21
Price / Net Operating Revenue (X) 6.087.325.578.4811.48
EarningsYield 0.010.010.020.020.01

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

About the Company - Qualitative Analysis

Metropolis Healthcare Ltd. is a Public Limited Listed company incorporated on 01/03/2006 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L73100MH2000PLC192798 and registration number is 192798. Currently Company is involved in the business activities of Activities of independent diagnostic/pathological laboratories. Company's Total Operating Revenue is Rs. 1216.54 Cr. and Equity Capital is Rs. 10.36 Cr. for the Year ended 31/03/2025.
INDUSTRYADDRESSCONTACT
Hospitals & Medical Services4th Floor, East Wing, Mumbai Maharashtra 400030Contact not found
Management
NamePosition Held
Mrs. Ameera Sushil ShahExe.Chairman & W T D
Mr. Hemant SachdevNon Exe.Non Ind.Director
Dr. Aparna RajadhyakshaNon Exe.Non Ind.Director
Dr. Sushil Kanubhai ShahNon Executive Director
Mr. Sanjay BhatnagarIndependent Director
Mr. Subramanian RanganathanIndependent Director
Ms. Purvi ShethIndependent Director
Mr. Vivek GambhirIndependent Director

FAQ

What is the intrinsic value of Metropolis Healthcare Ltd and is it undervalued?

As of 05 April 2026, Metropolis Healthcare Ltd's intrinsic value is ₹187.29, which is 55.83% lower than the current market price of ₹424.00, suggesting the stock is overvalued. This is calculated using the PE ratio method factoring in ROE (11.5 %), book value (₹69.1), dividend yield (0.24 %), and 5-year EPS CAGR.

What is the current share price and 52-week range of Metropolis Healthcare Ltd?

Metropolis Healthcare Ltd is trading at ₹424.00 as of 05 April 2026, with a FY2026-2027 high of ₹566 and low of ₹329. The stock is currently in the middle of its 52-week range. Market cap stands at ₹8,796 Cr..

How does Metropolis Healthcare Ltd's P/E ratio compare to its industry?

Metropolis Healthcare Ltd has a P/E ratio of 50.3, which is below the industry average of 75.17. This is broadly in line with or below the industry average.

Is Metropolis Healthcare Ltd financially healthy?

Key indicators for Metropolis Healthcare Ltd: ROCE of 14.7 % is moderate. Dividend yield is 0.24 %.

Is Metropolis Healthcare Ltd profitable and how is the profit trend?

Metropolis Healthcare Ltd reported a net profit of ₹146 Cr in Mar 2025 on revenue of ₹1,331 Cr. Compared to ₹215 Cr in Mar 2022, the net profit shows a declining trend.

Does Metropolis Healthcare Ltd pay dividends?

Metropolis Healthcare Ltd has a dividend yield of 0.24 % at the current price of ₹424.00. The company pays dividends, though the yield is modest.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Metropolis Healthcare Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE
Explore Industry-wise Stock Analysis Reports